[go: up one dir, main page]

CS136091A3 - Agents for determining thrombi and their application - Google Patents

Agents for determining thrombi and their application

Info

Publication number
CS136091A3
CS136091A3 CS911360A CS136091A CS136091A3 CS 136091 A3 CS136091 A3 CS 136091A3 CS 911360 A CS911360 A CS 911360A CS 136091 A CS136091 A CS 136091A CS 136091 A3 CS136091 A3 CS 136091A3
Authority
CS
Czechoslovakia
Prior art keywords
thrombi
agents
determining
application
determining thrombi
Prior art date
Application number
CS911360A
Other languages
Czech (cs)
Inventor
Paul D Bishop
Original Assignee
Zymo Genetics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymo Genetics filed Critical Zymo Genetics
Publication of CS136091A3 publication Critical patent/CS136091A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CS911360A 1990-05-10 1991-05-08 Agents for determining thrombi and their application CS136091A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52180590A 1990-05-10 1990-05-10
US52555690A 1990-05-18 1990-05-18

Publications (1)

Publication Number Publication Date
CS136091A3 true CS136091A3 (en) 1992-04-15

Family

ID=27060594

Family Applications (1)

Application Number Title Priority Date Filing Date
CS911360A CS136091A3 (en) 1990-05-10 1991-05-08 Agents for determining thrombi and their application

Country Status (4)

Country Link
AU (1) AU7982091A (en)
CS (1) CS136091A3 (en)
IE (1) IE911587A1 (en)
WO (1) WO1991016931A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726943A1 (en) * 1992-01-22 1996-08-21 Novo Nordisk A/S Activated factor xiii
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
EP1045026A1 (en) * 1999-04-16 2000-10-18 Aventis Behring Gesellschaft mit beschränkter Haftung A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding
ATE414765T1 (en) * 1998-09-23 2008-12-15 Csl Behring Gmbh TRANSGENIC ANIMAL WITH A DEFECTIVE GENE FOR CLOTTING FACTOR XIII AND ITS USE FOR TESTING WOUND HEALING AND BLEEDING
US6207877B1 (en) 1998-09-23 2001-03-27 Aventis Behring Gmbh Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416865A (en) * 1973-02-20 1983-11-22 Research Corporation Radiopharmaceuticals for localization of thromboembolic disease
DE3621371A1 (en) * 1986-03-12 1987-09-17 Behringwerke Ag GENETIC PRODUCTION OF FACTOR XIIIA
AU2258788A (en) * 1987-07-07 1989-01-30 Cytrx Biopool Ltd. Fibrin-binding compound and method
AU2645588A (en) * 1987-12-04 1989-06-15 Scripps Clinic And Research Foundation The von willebrand factor binding domain of factor viii
US5120537A (en) * 1989-06-14 1992-06-09 Oklahoma Medical Research Foundation Factor xa based anticoagulant compositions

Also Published As

Publication number Publication date
WO1991016931A1 (en) 1991-11-14
AU7982091A (en) 1991-11-27
IE911587A1 (en) 1991-11-20

Similar Documents

Publication Publication Date Title
GB9126354D0 (en) Pharmaceutical agents
NZ247205A (en) Intermediate compounds: 4-ethyl-5-fluoropyrimidine and 4-chloro-6-ethyl-5-fluoropyrimidine
GB2250921B (en) Diaper
EP0437216A3 (en) Silicone-dissolving and solubilizing agents
EP0466513A3 (en) Damping material
CS136091A3 (en) Agents for determining thrombi and their application
GB9111092D0 (en) Cleaning devices and methods
GB9019339D0 (en) Location determining arrangement
EP0456138A3 (en) Peptide-amidase and its application
GB2249788B (en) 3-amino-5-benzylidene-2-thioxo-thiazolidine-4-ones and cosmetic agents containing them
GB2250793B (en) Lateral joints between elongate members
EP0550595A4 (en) Methods
GB9017836D0 (en) Joint
GB9208908D0 (en) Contrast agents
EP0478906A3 (en) Intra-sorption agent
ZA913548B (en) Clot imaging agents and use thereof
EP0539587A4 (en) Antiretroviral agent
GB9022581D0 (en) Contrast agents
RU1806968C (en) T-joint
EP0438377A3 (en) Nematicide and fungicide agent
GB9014066D0 (en) Anti-nematode agents
IE900540L (en) Aminoethylthiazoles and aminoethyloxazoles
CA65374S (en) Construction block
RU1785669C (en) Knee-piece for treating affected joint
GB9017529D0 (en) Anti-coagulation agents